SERMOG Recommendations
Please see below a list of SERMOG recommendations that have been approved
SERMOG-01 Dual Biological Therapy for Inflammatory Bowel Disease in Adults
SERMOG-02 Overarching Policy on Licensed Doses or Dosing Schedules of High-Cost Drugs not Considered in NICE Technology Appraisal (TA) Guidance
SERMOG-03 Overarching Policy on Switching Between Biosimilars
SERMOG-04 Compact Oral Nutritional Supplements for Adults
SERMOG-05 High-Cost Drugs for Adults with Juvenile Idiopathic Arthritis (JIA)
SERMOG-06 Inflammatory Bowel Disease (IBD) High Cost Drug Pathway for Adults
SERMOG-07 Over the Counter (OTC) Prescribing Guidance
SERMOG-08 Anti-CGRP and Botulinum Toxin Type A Migraine Prevention Pathway
SERMOG-09 Immunomodulator Pathway For Adults with Psoriatic Arthritis
SERMOG-10 High Cost Immunomodulators for Psoriasis
- On Formulary Preferred
- On Formulary Second Line
- On Formulary Third Line
- Specialist Initiation
- Secondary Care Only
- Not Approved for Formulary